Allarity appoints Alex Epshinsky as CFO

Allarity Therapeutics (ALLR) announced the appointment of Alex Epshinsky as the Company’s new CFO and that the Company has granted equity awards on September 12, 2024 as a material inducement to the employment of Mr. Epshinsky. Most recently, he served as controller at Avenue Therapeutics (ATXI). In connection with the appointment of Mr. Epshinsky as CFO, Allarity granted Mr. Epshinsky employment inducement awards consisting of 55,555 restricted stock units with an effective grant date of September 12, 2024. The RSUs will vest in equal one-third installments on the first, second, and third anniversary of the Effective Date, subject to Mr. Epshinsky’s continuous employment and forfeiture on each vesting date.